CRBU
Caribou BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CRBU Profile
Caribou Biosciences, Inc.
A clinical-stage biopharmaceutical company that develops gene-editing cell therapies
2929 7th Street, Suite 105, Berkeley, California 94710
--
Caribou Biosciences, Inc., was incorporated in Delaware in October 2011. The company is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying the company's new CRISPR platform, CRISPR hybrid RNA-DNA or chRDNA to develop next-generation genome editing cell therapies.
